Delivery Order SPE2DB20D1109-SPE2DB25FN86V
Award Date
4/9/25
Potential Completion Date
4/30/25
Potential Value
$26K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with the ID SPE2DB22D3016|SPE2DB25FAMA0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BALVERSA 4 MG TABLET 56S, with a ceiling value of $25,623.23. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of BALVERSA 4 MG TABLET 56S, a pharmaceutical product. The $25,623.23 firm fixed-price delivery order has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,811.61 firm fixed-price delivery order covers the supply of BALVERSA 4 MG TABLET 28S, a medical product, with a period of performance through December 4, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $32,029.02 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 4562146297 BALVERSA 5 MG tablets. Under this contract, Amerisourcebergen will deliver 28 count packages of the specified cancer treatment medication to a location in Conshohocken, Pennsylvania within the period of performance of September 12, 2023 through October 3, 2023. No subcontractors or...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,920.91 firm fixed-price delivery order contract is for the supply of ORSERDU 345 MG TABLET 30S, which are likely pharmaceutical products. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,583.74 firm fixed-price Delivery Order contract covers the supply of LYBALVI 5-10 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through January 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $23,738.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $13,929.10 with a firm fixed price pricing type and a completion date of January 21, 2025. The contract provides pharmaceutical products, including the ORSERDU 345 MG TABLET 30S, to support military treatment facilities, veterans' healthcare programs, and other federal medical...
This federal contract award SPE2DB22D3009|SPE2DB25FAL29 was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of 4566644236 ! LYBALVI 20-10 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $10,892.04. The contract type is Delivery Order with a Firm Fixed Price pricing structure. The ultimate completion date for this contract is December 9, 2024. The contract was awarded on December 7, 2024 and...
This federal contract award, valued at $22,175.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...